2 completed, 1 active not recruiting, 1 not yet recruiting, 1 recruiting. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 2, Active not recruiting 1, Not yet recruiting 1, Recruiting 1, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
Follow Kidney Transplant Failure and Rejection: new trials by email Literature Review of Kidney Transplant Failure and Rejection trials Research Report on Kidney Transplant Failure and Rejection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants ECP-DL treated mononuclear cell infusion - Kidney Transplant Failure and Rejection, Kidney Transplant; Complications | Phase 1 | Not yet recruiting | Northwestern University | 24 | 2026-08-30 | 2026-08-10 |
| Immunological Tolerance in Patients With Mismatched Kidney Transplants Donor CD34+, CD3+. and belumosudil - End Stage Kidney Disease, Immunological Tolerance | Phase 1 | Active not recruiting | University of California, Los Angeles | 16 | 2023-07-07 | 2025-11-26 |
| Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants Conditioning and Stem cell infusion - End Stage Kidney Disease, Immunological Tolerance | Phase 1 | Recruiting | University of California, Los Angeles | 10 | 2022-12-21 | 2025-11-26 |
| Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients Envarsus, Tacrolimus - Kidney Transplant; Complications, Kidney Transplant Failure and Rejection | Phase 1 | Unknown | California Institute of Renal Research | 50 | 2018-07-11 | 2023-02-09 |
| Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients immediate-release tacrolimus, extended release tacrolimus - Kidney Transplant Failure and Rejection | Phase 1 / Phase 2 | Completed | University of Minnesota | 18 | 2018-05-08 | 2021-04-15 |
| Clazakizumab in Highly-HLA Sensitized Patients Awaiting Renal Transplant Clazakizumab - Kidney Failure, Chronic, End-Stage Renal Disease | Phase 1 / Phase 2 | Completed | Stanley Jordan, MD | 20 | 2018-02-27 | 2026-10-30 |
Rejection, Psychology (6) · Kidney Failure, Chronic (3) · Renal Insufficiency, Chronic (2)
Behavior (6) · Social Behavior (6) · Chronic Disease (3) · Disease Attributes (3) · Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Kidney Diseases (3) · Male Urogenital Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Renal Insufficiency (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Renal Insufficiency, Chronic (1)
Tacrolimus (2) · CD3 Complex (1) · belumosudil (1) · clazakizumab (1)
University of California, Los Angeles (2) · California Institute of Renal Research (1) · Northwestern University (1) · Stanley Jordan, MD (1) · University of Minnesota (1)
United States (5)
Arman Faravardeh, MD (1) · Jeffrey Veale, MD (1) · Jennifer Schneiderman, MD, MS (1) · Joseph Leventhal, MD, PhD (1) · Stanley Jordan, MD (1) · Susan Marino, PhD (1)